Received Feb 11, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (NO BRAND NAME) | UNKNOWN MANUFACTURER | 2 | UNK | — |
flu like symptoms; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of influenza-like symptoms in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. Previously administered products included Shingles vaccine with an associated reaction of no adverse event (received 1st dose of vaccine on an unknown date,was fine). On an unknown date, the patient received the 2nd dose of Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced influenza-like symptoms (Verbatim: flu like symptoms). The outcome of the influenza-like symptoms was resolved (duration 24 hrs). It was unknown if the reporter considered the influenza-like symptoms to be related to Shingles vaccine. It was unknown if the company considered the influenza-like symptoms to be related to Shingles vaccine. Additional Information: GSK Receipt Date: 29-JAN-2025 This case was reported by a patient via interactive digital media. The patient had flu like symptoms for only 24 hours.